Careers
Chrisy Ngilneii's Profile
B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)
Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on view more..
Written / Edited / Medically Reviewed
New Treatment may Help Use Anxiety and Stress for Productivity
New pathway to treat anxiety has been identified by recent research at the University of Alberta, Faculty of Medicine & Dentistry. This includes new ways to understand processes of stress and anxiety to open a door for drug targets to reverse it.
Sibling’s Rheumatoid Arthritis – A Risk for Acute Coronary Syndrome
Siblings of people with rheumatoid arthritis (RA) are at an increased risk of acute coronary syndrome, research finds. Patients with rheumatoid arthritis and their siblings are more likely to suffer from acute coronary syndrome respectively than matched comparators.
Calcitriol May Improve Chances of Survival in Ovarian Cancer
New ovarian cancer target has been identified by experts at the Houston Methodist Cancer Center. Preclinical research shows that malignant cells are linked to supportive fibroblasts and they can be hit with Calcitriol.
Potential Treatment Target for Atherosclerosis Identified
Protective mechanism against atherosclerosis has been discovered by a research team who finds that the receptor BAFF has anti-inflammatory properties which have a positive effect on plaque size and atherosclerosis risk.
Plug and Play Platform – Single-dose Vaccine for Zika Virus, HIV, Ebola
Vaccines for diseases such as AIDS, zika, and ebola using a novel 'plug and play' viral platform has been developed by experts from GeoVax. This vaccine platform delivers single-dose vaccines that fully protect against emerging infectious diseases.
